ArticleBritish journal of cancer2024

Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer.

John Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.